Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FVBD8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,949
Award facts
- Contract value 100% obligated
- $37,949.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $37,949.15 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed price delivery order, awarded on May 30, 2025, with completion expected by June 2, 2025, represents a direct procurement of pharmaceutical inventory. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle extending through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. The IDC encompasses a broad range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract reflects the company's established capability to meet federal medical supply requirements and represents part of DLA's broader pharmaceutical supply chain strategy, which is planning to establish next-generation prime vendor global program contracts with multiple regional award recipients.
Quick answers
Who was awarded contract SPE2DB25FVBD8?
SPE2DB25FVBD8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FVBD8 worth?
The government has obligated $37,949 on SPE2DB25FVBD8.
Is contract SPE2DB25FVBD8 an order under another contract?
Yes. SPE2DB25FVBD8 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVBD8 competed?
The extent of competition for SPE2DB25FVBD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award